Pure Global: Brazil's MedTech Shift - Cracking ANVISA's New Digital Labyrinth.

Impossibile aggiungere al carrello

Puoi avere soltanto 50 titoli nel carrello per il checkout.

Riprova più tardi

Rimozione dalla Lista desideri non riuscita.

Riprova più tardi

Non è stato possibile aggiungere il titolo alla Libreria

Per favore riprova

Non è stato possibile seguire il Podcast

Per favore riprova

Esecuzione del comando Non seguire più non riuscita

Pure Global: Brazil's MedTech Shift - Cracking ANVISA's New Digital Labyrinth.

Ascolta gratuitamente

Vedi i dettagli del titolo

3 mesi a soli 0,99 €/mese

Dopo 3 mesi, 9,99 €/mese. Si applicano termini e condizioni.

A proposito di questo titolo

This week on LATAM MedTech Insights, we dive into the mandatory transition to ANVISA's new digital submission platform in Brazil. While the goal is to accelerate approvals, the reality is a wave of new, technical challenges stalling market access for many MedTech companies. We explore the hidden pitfalls of this digital shift, moving beyond traditional regulatory concerns to the critical importance of technical and IT compliance. Discover why perfectly valid clinical dossiers are being rejected for reasons like metadata errors and incompatible file formats, and what this means for your 2026 registration strategy. **Case Study Spotlight:** A European manufacturer of advanced diagnostic software had their Brazilian market entry delayed by over six months. Their clinically-sound dossier was rejected three times by ANVISA's new platform. The problem? Not their data, but undocumented digital formatting requirements. Find out what they were and how to avoid them. **Key Questions Answered:** * Why is ANVISA’s promise of faster digital approvals leading to unexpected delays? * What are the most common, yet undocumented, digital errors causing submission rejections? * How must you adapt your dossier preparation strategy for a digital-first review? * Is your current local partner in Brazil equipped to handle these new IT challenges? * What specific metadata is causing the most frequent mismatches in the new portal? * How can you pre-validate your submission package to avoid cryptic platform errors? * What is the true cost of a failed digital submission in terms of time and resources? Struggling to navigate the complexities of global market access? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies. We combine local expertise in over 30 markets, including Brazil, with advanced AI and data tools to streamline your registration and ensure compliance. Let us be your local representative and technical navigator. Contact us at info@pureglobal.com or visit https://pureglobal.com/.

Ancora nessuna recensione